Status:
RECRUITING
GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders
Lead Sponsor:
CHU de Quebec-Universite Laval
Collaborating Sponsors:
CISSS de Chaudière-Appalaches
Ciusss de L'Est de l'Île de Montréal
Conditions:
Major Neurocognitive Disorder
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to ...
Detailed Description
: The GPS project is part of the desire to keep seniors with major neurocognitive disorder (MCND) in their homes for as long as possible. Medication can contribute to cognitive loss in seniors and aff...
Eligibility Criteria
Inclusion
- All seniors (65 years of age or older) undergoing cognitive evaluation OR referred to a memory clinic OR having been diagnosed with cognitive impairment within the last year OR with MCND and followed up at home AND,
- referred to the pharmacist, for the FMGs exposed
- taking prescription medications
Exclusion
- Seniors in palliative care OR
- unable to answer questionnaires in French AND without a caregiver.
Key Trial Info
Start Date :
September 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04889794
Start Date
September 27 2021
End Date
December 1 2026
Last Update
August 22 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GMF Bordeaux-Cartierville
Montreal, Quebec, Canada, H3M 2X6
2
GMF Abénakis
Saint-Georges, Quebec, Canada, G5Y 5L6